Status:
COMPLETED
Genetic Research on High Myopic Individuals in Northern China
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Conditions:
High Myopia
Eligibility:
All Genders
1-80 years
Brief Summary
HM, which can dramatically cripple the eyesight of those affected, is a rampant ophthalmic disorder around the globe. It is in recent years that substantial studies covering the relationship between d...
Detailed Description
As a serious pattern of myopia, high myopia (HM) generally refers to a condition where the spherical equivalent (SE) refraction exceeds -6.00 diopters (D) or the axial length (AL) is longer than 26.00...
Eligibility Criteria
Inclusion
- HM participants are characterized by AL ≥ 26.00 mm or SE ≤ -6.00 D in at least one eye.
Exclusion
- Individuals with other ocular or systemic connective tissue diseases were excluded.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
1340 Patients enrolled
Trial Details
Trial ID
NCT06204211
Start Date
May 1 2022
End Date
August 31 2023
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liping Du
Zhengzhou, Henan, China, 450052